SPER Market Research

Dr. Narendra Kumar

Director

Dr. Narendra Kumar serves as a distinguished Director at SPER Market Research®, bringing an exceptional depth of understanding of human behavior and societal dynamics cultivated through over three decades of experience within both government and private sector settings in psychology and psychiatry. His extensive background provides a unique and invaluable perspective to the market research domain, allowing for a nuanced comprehension of consumer motivations, societal trends, and the psychological factors that influence market behavior. This profound understanding enriches the strategic insights and analytical capabilities of SPER Market Research®.

His extensive tenure in both governmental and private organizations within the fields of psychology and psychiatry has equipped Dr. Kumar with a comprehensive understanding of individual and collective human experiences. This multifaceted background allows him to approach market research challenges with a deep appreciation for the underlying psychological drivers that shape consumer choices and societal trends. His ability to synthesize insights from these diverse fields brings a unique rigor and depth to the analysis conducted at SPER Market Research®, enhancing the accuracy and relevance of the findings.

As a Director, Dr. Kumar's wealth of experience significantly contributes to the strategic direction and research methodologies employed by SPER Market Research®. His profound understanding of human psychology and behavior enhances the ability of the firm to uncover deeper insights into market dynamics, consumer preferences, and the impact of psychological factors on market trends. His leadership fosters a research environment that values a holistic and human-centric approach, ultimately delivering more insightful and impactful market intelligence to clients.

Dr. Upendra Nagaich

Founder & CEO

Dr. Upendra Nagaich stands at the forefront of healthcare innovation, embodying the essence of an entrepreneurial visionary. With a career spanning over 2 decades, Dr. Nagaich has made significant contributions to the healthcare industry through his groundbreaking ventures, pioneering research, and unwavering commitment to improving global health outcomes.

Armed with a diverse skill set and a deep understanding of the healthcare landscape, Dr. Nagaich embarked on his entrepreneurial journey with a clear vision—to revolutionize healthcare delivery and improve patient outcomes on a global scale.

Under Dr. Nagaich's leadership, the startup rapidly gained traction, attracting investment from leading venture capital firms and garnering industry recognition for its innovative solutions. His ability to identify market gaps and develop scalable, tech-enabled healthcare solutions positioned him as a trailblazer in the field, earning him accolades as a visionary entrepreneur.

In addition to his entrepreneurial pursuits, Dr. Nagaich plays an active role in shaping the future of healthcare through his involvement in industry organizations and advisory roles. He serves on the boards of numerous healthcare startups, providing strategic guidance and mentorship to emerging entrepreneurs. Furthermore, he is a sought-after speaker and thought leader, sharing his insights and expertise at conferences and symposiums globally.

Dr. Nagaich has authored more than 160 influential publications in reputed scientific journals, filed 13 patents, highlighting his keen insights into drug formulation and delivery technologies. His groundbreaking research has garnered recognition and acclaim from peers, further establishing him as a thought leader in the pharmaceutical community.

Overall, Dr. Upendra Nagaich's lifelong dedication to pharmaceutical education and research has left an indelible mark on the industry. His passion for innovation and commitment to improving global healthcare continue to inspire and shape the future of healthcare for generations to come.

Recipient of many prestigious awards:

• Top Transformational Leaders to follow in 2024
• Global Business Leader of the Year Award
• 100 Most Impactful Healthcare Leaders - Global Listing at World Health & Wellness Congress
• National Secretary, Society of Pharmaceutical Education & Research, India
• Editor-in-Chief, Journal of Advanced Pharmaceutical Technology & Research
  [A Web of Science (WoS), PubMed and SCOPUS indexed international research journal published by Wolters Kluwer Health, Philadelphia, USA]

Mike Teiler

Advisor

Mike Teiler stands as a highly accomplished Advisor at SPER Market Research®, bringing an exceptional depth of pharmaceutical expertise and practical experience garnered over 35 years within the industry. His extensive career includes significant tenures at leading global pharmaceutical companies such as Teva Pharmaceuticals, Sun Pharma, and Taro Pharmaceuticals, alongside his role as a trusted advisor to numerous other pharma companies and emerging start-ups. This broad exposure across diverse organizations provides him with a comprehensive understanding of the pharmaceutical landscape, from research and development to commercialization.

Throughout his distinguished career, Mr. Teiler has held a multitude of Research & Development roles, progressing from a bench formulator to Vice President of R&D. This journey has provided him with a granular understanding of the drug development process from its earliest stages through to market launch. Notably, he has a proven track record of establishing critical operational frameworks, having successfully implemented Portfolio Management, Project Management, Launch Management, and Governance processes on multiple occasions. This expertise in building robust and efficient systems is invaluable in navigating the complexities of the pharmaceutical market.

As an Advisor to SPER Market Research®, Mr. Teiler's profound pharmaceutical knowledge and his experience in strategic planning and execution are instrumental in providing insightful guidance. His ability to establish and optimize key processes, coupled with his deep understanding of the R&D lifecycle and market dynamics, makes him a valuable asset in helping SPER Market Research® deliver impactful and relevant market intelligence to its clients within the pharmaceutical sector. His extensive network and industry insights further enhance the firm's capabilities in this critical domain.

Dr. Dinesh Jaiswal

Independent Director

Dr. Dinesh Jaiswal brings an unparalleled depth of scientific and organizational leadership to his role as Advisor at SPER Market Research®, cultivated through over 40 years of impactful experience in the pharmaceutical industry. His expertise spans the entire spectrum of product development, from formulation and process optimization across various dosage forms to robust analytical development. A testament to his capabilities is his significant contribution to the successful market launch of products like Lexapro, showcasing his ability to translate scientific innovation into tangible market successes.

Beyond his scientific acumen, Dr. Jaiswal excels as an organizational leader and mentor, fostering a learning-centric environment focused on delivering tangible results. His underlying philosophy centers on cultivating "scientist leaders" who possess a strong understanding of both the scientific and business aspects of the pharmaceutical field. His profound understanding of GMP operations, emphasizing organized data management and unwavering rigor, ensured a decade of successful audit inspections without a single observation during his management of a GMP stability organization, a direct result of his strong documentation practices and the process-oriented culture he nurtured.

As a trusted advisor and counselor on scientific risk management, Dr. Jaiswal demonstrates strong decision-making capabilities grounded in both regulatory guidelines (FDA, EMA, and ICH) and sound scientific rationale. His early adoption of risk management principles underscores his proactive approach to drug product development. With over 30 years of experience in both industry and academia, including significant contributions to bringing key drugs like Linzess and Nemenda to market, Dr. Jaiswal's wealth of knowledge and strategic insights provide invaluable guidance to SPER Market Research® and its clients.

Dr. Awanish Kumar Pandey

VP, Research & Strategy

Dr. Awanish Kumar Pandey spearheads Research & Strategy at SPER Market Research®, bringing a wealth of experience honed over a distinguished career in market research and competitive intelligence. His previous tenures at prominent organizations such as Course5 Intelligence and MarketsandMarkets have equipped him with a comprehensive understanding of the industry landscape. Dr. Pandey's strong academic foundation, including an M.Pharm and PhD, provides him with a specialized lens through which to analyze the healthcare sector, delivering incisive strategic guidance within the pharmaceutical, MedTech, and allied domains.

His professional journey reflects a consistent focus on generating actionable intelligence through rigorous research and insightful analysis. Dr. Pandey possesses a proven track record in a diverse range of areas, including in-depth market intelligence gathering, insightful competitive benchmarking, strategic and business consulting, and impactful thought leadership. This multifaceted experience allows him to approach complex industry challenges with a holistic perspective, identifying key trends and opportunities to inform strategic decision-making.

In his current role at SPER Market Research®, Dr. Pandey is instrumental in driving impactful research initiatives and shaping the company's strategic direction. By leveraging his extensive experience and deep understanding of market dynamics, he is dedicated to providing clients with the critical insights necessary to navigate the evolving healthcare landscape and achieve their business objectives. His leadership in research and strategy ensures that SPER Market Research® remains at the forefront of delivering high-value market intelligence.

Deepak Sharma

Chief Technical Officer

Mr. Deepak Sharma serves as the Chief Technology Officer at SPER Market Research®, bringing over 15 years of extensive experience in website development and digital media strategy to the organization. His demonstrated history within the market research industry provides him with a unique understanding of how digital solutions can be leveraged to enhance business growth and client engagement. Mr. Sharma's proficiency spans critical areas such as digital strategy formulation, seamless digital media integration, effective digital marketing campaign management, and robust web development practices, ensuring a strong and impactful online presence for the company.

With a masters focused on bridging the gap between businesses and their clients through digital channels, Mr. Sharma is adept at crafting and implementing digital strategies that drive business objectives. His skills in digital marketing and media integration are crucial in today's interconnected world, enabling SPER Market Research® to effectively communicate its value proposition and connect with its target audience. His leadership in web development ensures the creation and maintenance of a user-friendly and informative online platform that serves as a key touchpoint for clients and stakeholders.

Mr. Sharma's proven track record of over a decade and a half in the market research sector underscores his ability to translate technical expertise into tangible business outcomes. His strategic vision for digital integration and web development plays a vital role in SPER Market Research®'s overall growth strategy, ensuring the company remains at the forefront of leveraging digital technologies to deliver exceptional value to its clients and solidify its position as a leader in the market research landscape.